Kowichi Jimbow

Sapporo, 0600042, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma.

A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma.

Journal: International journal of molecular sciences

Published: February 10, 2023

Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development.

Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development.

Journal: Cancers

Published: October 25, 2022

Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.

Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.

Journal: International journal of molecular sciences

Published: May 01, 2022

Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.

Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.

Journal: International journal of molecular sciences

Published: August 02, 2020

Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells.

Approach for the Derivation of Melanocytes from Induced Pluripotent Stem Cells.

Journal: The Journal of investigative dermatology

Published: February 13, 2017

Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.

Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.

Journal: Nanomedicine (London, England)

Published: October 17, 2014

TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).

TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).

Journal: Journal of dermatological science

Published: September 06, 2013

SIRT1 regulates lamellipodium extension and migration of melanoma cells.

SIRT1 regulates lamellipodium extension and migration of melanoma cells.

Journal: The Journal of investigative dermatology

Published: March 25, 2013

T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles.

T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles.

Journal: Nanomedicine (London, England)

Published: October 17, 2012

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Journal: Journal of skin cancer

Published: August 09, 2012

Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array.

Cell behavior observation and gene expression analysis of melanoma associated with stromal fibroblasts in a three-dimensional magnetic cell culture array.

Journal: Biotechnology progress

Published: May 21, 2012

Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.

Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.

Journal: Biochemical pharmacology

Published: May 07, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026